Novo Nordisk A/S (NVO) Earnings: Quarterly Revenue, EPS and Margins

How are revenue and profit of Novo Nordisk A/S developing? This page lists revenue, operating income, net income and earnings per share by quarter, taken from the company's published reports.

Novo Nordisk A/S latest annual figures (FY 2025)

In the latest reported fiscal year (FY 2025), Novo Nordisk A/S generated revenue of 309.06 DKK bn. The largest segment is Diabetes and Obesity care with 289.46 DKK bn, about 93.7 % of total segment revenue. From gross margin (81.0 %) through operating margin (41.3 %) to net margin (33.1 %), the Sankey diagram shows how much of each revenue dollar remains at each stage of the income statement.

Novo Nordisk A/S revenue by segment (FY 2025)

Frequently asked questions about Novo Nordisk A/S

When does Novo Nordisk A/S report earnings?

Novo Nordisk A/S publishes quarterly results four times a year. The quarters listed on this page follow the company's fiscal calendar as reported in its filings.

What was Novo Nordisk A/S revenue in the last fiscal year?

Novo Nordisk A/S reported revenue of 309.06 DKK bn (FY 2025).

How profitable is Novo Nordisk A/S?

Net margin was 33.1 % (FY 2025), meaning that share of every revenue unit remained as profit.

More on Novo Nordisk A/S

• Novo Nordisk A/S stock: revenue, segments and business model
• Novo Nordisk A/S valuation and P/E